Radiologix slides in 2Q
Service fees fell 9.1% in the second quarter for Radiologix, a national provider of diagnostic imaging services, to $65 million versus $71.5 million for the second quarter ended June 30. The drop was due primarily to reduced patient volume related to
Service fees fell 9.1% in the second quarter for Radiologix, a national provider of diagnostic imaging services, to $65 million versus $71.5 million for the second quarter ended June 30. The drop was due primarily to reduced patient volume related to increased competition in key markets. The numbers were up about 1%, however, compared with the previous quarter, during which Radiologix generated $64.4 million in service fees. The company achieved net income of $276,000 for the second quarter of 2003, compared with net income of $4.8 million for the previous year period and a net loss of $4.6 million for first quarter 2003. Company executives view the sequential improvement as evidence of stabilization in Radiologix' core business. Net income improved partly as a result of cost-cutting measures.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
